Cargando…
SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022
In this article, three important clinical trials presented at the 2022 European Society of Cardiology Congress have been selected for a brief discussion. These are the SECURE, ADVOR and REVIVED-BCIS2 trials, all of which are investigator-initiated studies whose findings are of interest given their p...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Radcliffe Cardiology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947931/ https://www.ncbi.nlm.nih.gov/pubmed/36845215 http://dx.doi.org/10.15420/ecr.2022.43 |
| _version_ | 1784892668516499456 |
|---|---|
| author | Mendieta, Guiomar |
| author_facet | Mendieta, Guiomar |
| author_sort | Mendieta, Guiomar |
| collection | PubMed |
| description | In this article, three important clinical trials presented at the 2022 European Society of Cardiology Congress have been selected for a brief discussion. These are the SECURE, ADVOR and REVIVED-BCIS2 trials, all of which are investigator-initiated studies whose findings are of interest given their potential to impact clinical practice, ultimately improving current patient care and clinical outcomes. |
| format | Online Article Text |
| id | pubmed-9947931 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Radcliffe Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99479312023-02-24 SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 Mendieta, Guiomar Eur Cardiol ESC 2022 Highlights In this article, three important clinical trials presented at the 2022 European Society of Cardiology Congress have been selected for a brief discussion. These are the SECURE, ADVOR and REVIVED-BCIS2 trials, all of which are investigator-initiated studies whose findings are of interest given their potential to impact clinical practice, ultimately improving current patient care and clinical outcomes. Radcliffe Cardiology 2022-12-19 /pmc/articles/PMC9947931/ /pubmed/36845215 http://dx.doi.org/10.15420/ecr.2022.43 Text en Copyright © 2022, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
| spellingShingle | ESC 2022 Highlights Mendieta, Guiomar SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 |
| title | SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 |
| title_full | SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 |
| title_fullStr | SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 |
| title_full_unstemmed | SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 |
| title_short | SECURE, ADVOR and REVIVED: Clinical Trials Presented at ESC 2022 |
| title_sort | secure, advor and revived: clinical trials presented at esc 2022 |
| topic | ESC 2022 Highlights |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947931/ https://www.ncbi.nlm.nih.gov/pubmed/36845215 http://dx.doi.org/10.15420/ecr.2022.43 |
| work_keys_str_mv | AT mendietaguiomar secureadvorandrevivedclinicaltrialspresentedatesc2022 |